Clinical Trial Update: A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 study of Factor XIII Concentrate in subjects with congenital Factor XIII deficiency is completed. Results were posted on 2012-07-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Xiii Deficiency

Drugs mentioned

• Factor XIII concentrate (Coagulation factor XIII concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Factor XIII Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04